N = 74 No (%) | Character |
55 (74.3) 9 (12.2%) 5 (6.8) 5 (6.8) | Pathology of the tumor IDC IDC with diffuse DCIS ILC Phylloides tumor |
5 (6.8) 7 (9.5%) 10 (13.5) 33 (44.6) 19 (25.7) | TNM stage >10 cm T1N0M0 T2N0M0 T2N1M0 T3N1M0 |
19 (25.7) | Neo-adjuvant chemotherapy |
50 (67.5) | Adjuvant chemotherapy |
69 (93%) | Hormonal therapy |
52 (70.3) | Adjuvant radiotherapy |
28 (37.8) 16 (21.6) 20 (27) 10 (13.5) | Incision approach Elliptical incision Peri-areolar incision Lateral mammary fold incision Infra-mammary incision |
5 (6.8) 59 (79.7) 10 (13.5) | Axillary incision Un needed Through the same incision approach Through separate incision |
5 (6.8) 51 (68.9) 18 (24.3) | Axillary management Un needed Formal evacuation SLN |
14 (18.9) | Implant insertion |
10 (13.5) 4 (5.4) 25 (33.8) 10 (13.5) 4 (5.4) 4 (5.4) 5 (6.8) 2 (2.7) | Complications NAC necrosis Donor site haemorrhage Donor site seroma formation Resection site seroma formation Donor site wound evisceration Donor site wound infection Breast wound infection Exposure of implant |